Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 6,010.00
+160.00 (2.74%)
Aug 12, 2026, 3:30 PM KST
Tdspharm Market Cap
Tdspharm has a market cap or net worth of 32.35 billion as of August 12, 2026. Its market cap has decreased by -46.82% in one year.
Market Cap
32.35B
Enterprise Value
17.96B
Revenue
30.41B
Ranking
n/a
PE Ratio
6.11
Stock Price
6,010.00
ChartMarket Cap Chart
Since August 21, 2024, Tdspharm's market cap has decreased from 287.56B to 32.35B, a decrease of -88.75%. That is a compound annual growth rate of -66.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 32.35B | -40.61% |
| Dec 30, 2025 | 54.47B | -25.60% |
| Dec 30, 2024 | 73.22B | -74.54% |
| Aug 21, 2024 | 287.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.03T |
| Celltrion | 45.70T |
| ALTEOGEN | 21.24T |
| Samsung Epis Holdings | 10.22T |
| MYUNGMOON Pharm co.,Ltd | 38.78B |
| Gencurix | 38.66B |
| HASS Corp. | 33.38B |
| BCWORLD PHARM. | 31.67B |